MedTrace Logo

Evaluation of Use of Brain Activity Monitoring Dynamics in ADHD

NCT02625805 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-06-16

No results posted yet for this study

Summary

This study evaluates the ability to support diagnosis and monitor of the dynamics in ADD/ADHD subjects with an easy to use EEG Device.

Conditions

  • ADHD

Interventions

DEVICE

EEG monitoring (MindWave by NeuroSky)

EEG evaluation will be conducted for duration of 10 minutes. 5 minutes without auditory stimulation and 5 minutes with auditory stimulation performed using standard headphone or earphones to reduce external noises. Additional EEG monitoring will be performed during performance of a computerized test using MindWave Headset.

DEVICE

EEG monitoring (EPOC by Emotiv)

EEG evaluation will be conducted for duration of 10 minutes. 5 minutes without auditory stimulation and 5 minutes with auditory stimulation performed using standard headphone or earphones to reduce external noises.

DRUG

Methylphenidate

Methylphenidate will be administered to each of the study participants in both groups in one of the two days on the study selected randomly.

Sponsors & Collaborators

  • Brainmarc Ltd.

    lead INDUSTRY

Principal Investigators

  • Yuval Bloch, MD · Shalvata Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2016-10-31
Completion
2017-01-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02625805 on ClinicalTrials.gov